• Sofwave reported results from a randomized controlled study of its Pure Impact VIP platform using PlyoPulse EMS, published in Aesthetic Surgery Journal.
• The trial showed improved objective functional muscle performance versus an untreated control group, with benefits sustained at follow-up.
• Participants also reported better body perception and stronger, firmer-feeling muscles, supporting a positioning beyond cosmetic outcomes.
• The treatment was well tolerated, with no adverse events reported, which could aid broader clinical adoption and commercialization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sofwave Medical Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608310800PRIMZONEFULLFEED9817450) on August 31, 2026, and is solely responsible for the information contained therein.